Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease

被引:21
作者
Hashimoto, T
Tokuda, T
Hanyu, N
Tabata, K
Yanagisawa, N
机构
[1] Shinshu Univ, Sch Med, Dept Med 3, Matsumoto, Nagano 3908621, Japan
[2] Iida Municipal Hosp, Dept Neurol, Iida 3958502, Japan
[3] Saku Cent Hosp, Dept Neurol, Minami Saku 3840301, Japan
[4] Kanto Rosai Hosp, Kawasaki, Kanagawa 2118510, Japan
关键词
levodopa; malignant syndrome; Parkinson's disease; creatine kinase; dehydration;
D O I
10.1016/S1353-8020(02)00119-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A symptom complex identical to neuroleptic malignant syndrome (MS) is known to develop in patients with idiopathic Parkinson's disease (PD) or other forms of parkinsonism on long-term treatment with anti-parkinsonian drugs. In order to clarify the risk factors for parkinsonian MS, the authors retrospectively reviewed charts of consecutive inpatients with PD in the neurological departments at the three hospitals and found 16 episodes of parkinsonian MS in 14 patients. A survey of health status preceding MS disclosed that deterioration of parkinsonian symptoms alone may induce MS, while association of major risk factors, i.e. rapid discontinuation of anti-parkinsonian drugs, dehydration or infection may precipitate or exacerbate MS. Cerebral vascular disorders, mechanical brain injury or physiological stress could be other risk factors leading to MS. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:S25 / S30
页数:6
相关论文
共 22 条
[1]  
ADDONIZIO G, 1986, AM J PSYCHIAT, V143, P1587
[2]  
ANDREOLI TE, 1992, CECIL TXB MED, P499
[3]   NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].
BURKE, RE ;
FAHN, S ;
MAYEUX, R ;
WEINBERG, H ;
LOUIS, K ;
WILLNER, JH .
NEUROLOGY, 1981, 31 (08) :1022-1026
[4]  
CAROFF SN, 1980, J CLIN PSYCHIAT, V41, P79
[5]  
Delay J., 1968, HDB CLINICAL NEUROLO, P248
[6]   HYPERTHERMIA AFTER DISCONTINUANCE OF LEVODOPA AND BROMOCRIPTINE THERAPY - IMPAIRED DOPAMINE-RECEPTORS A POSSIBLE CAUSE [J].
FIGATALAMANCA, L ;
GUALANDI, C ;
DIMEO, L ;
DIBATTISTA, G ;
NERI, G ;
RUSSO, FL .
NEUROLOGY, 1985, 35 (02) :258-261
[7]   A NEUROLEPTIC MALIGNANTLIKE SYNDROME DUE TO LEVODOPA THERAPY WITHDRAWAL [J].
FRIEDMAN, JH ;
FEINBERG, SS ;
FELDMAN, RG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (19) :2792-2795
[8]  
Fujitake J, 1984, Rinsho Shinkeigaku, V24, P371
[9]   LEVODOPA WITHDRAWAL SYNDROME IDENTICAL TO NEUROLEPTIC MALIGNANT SYNDROME [J].
GIBB, WRG ;
GRIFFITH, DNW .
POSTGRADUATE MEDICAL JOURNAL, 1986, 62 (723) :59-60
[10]  
GURRERA RJ, 1992, J CLIN PSYCHIAT, V53, P56